Michael Allingham

Michael Allingham, M.D., Ph.D., is a retina trained clinician scientist with expertise in the diagnosis and treatment of macular diseases including diabetic retinopathy and edema, macular degeneration and retinal vein occlusion. Dr. Allingham attended Duke University where he earned a B.S. in Chemistry with Distinction. He pursued his M.D. / Ph.D. at the University of North Carolina. Upon completing his M.D. / Ph.D., he returned to Duke for his internship, residency in ophthalmology and fellowship in medical retina before accepting a faculty position in the Duke Eye Center Department of Ophthalmology where he is currently Assistant Professor.

Dr. Allingham's research is focused on the development of new therapies and diagnostics for macular diseases and he is particularly interested in mechanisms of vision loss due to macular edema as seen in diabetes and vein occlusion. He is active in basic laboratory research, clinical research focused on computerized analysis of retinal imaging as well as clinical trials for macular diseases. His research has received funding from the National Institutes of Health and he has published over 20 peer reviewed journal articles, reviews and book chapters.